SG10202007719TA - Compositions, methods and uses for inducing viral growth - Google Patents
Compositions, methods and uses for inducing viral growthInfo
- Publication number
- SG10202007719TA SG10202007719TA SG10202007719TA SG10202007719TA SG10202007719TA SG 10202007719T A SG10202007719T A SG 10202007719TA SG 10202007719T A SG10202007719T A SG 10202007719TA SG 10202007719T A SG10202007719T A SG 10202007719TA SG 10202007719T A SG10202007719T A SG 10202007719TA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- methods
- viral growth
- inducing viral
- inducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12026208P | 2008-12-05 | 2008-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202007719TA true SG10202007719TA (en) | 2020-09-29 |
Family
ID=42231513
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201503671TA SG10201503671TA (en) | 2008-12-05 | 2009-12-04 | Compositions, methods and uses for inducing viral growth |
| SG10202007719TA SG10202007719TA (en) | 2008-12-05 | 2009-12-04 | Compositions, methods and uses for inducing viral growth |
| SG2011040961A SG171972A1 (en) | 2008-12-05 | 2009-12-04 | Compositions, methods and uses for inducing viral growth |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201503671TA SG10201503671TA (en) | 2008-12-05 | 2009-12-04 | Compositions, methods and uses for inducing viral growth |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2011040961A SG171972A1 (en) | 2008-12-05 | 2009-12-04 | Compositions, methods and uses for inducing viral growth |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US8871487B2 (es) |
| EP (1) | EP2366024B1 (es) |
| JP (2) | JP5728742B2 (es) |
| KR (1) | KR101784951B1 (es) |
| CN (2) | CN105219734B (es) |
| AR (1) | AR074483A1 (es) |
| AU (1) | AU2009322175B2 (es) |
| BR (2) | BR122020015754B8 (es) |
| CA (1) | CA2745962C (es) |
| CO (1) | CO6390063A2 (es) |
| CU (1) | CU20110128A7 (es) |
| HR (1) | HRP20191324T1 (es) |
| IL (2) | IL213389B (es) |
| MX (2) | MX2011005886A (es) |
| MY (1) | MY178195A (es) |
| NZ (1) | NZ593415A (es) |
| SG (3) | SG10201503671TA (es) |
| TW (2) | TWI573874B (es) |
| WO (1) | WO2010065911A1 (es) |
| ZA (2) | ZA201104364B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR122020015754B8 (pt) * | 2008-12-05 | 2021-04-06 | Takeda Vaccines Inc | métodos para aumentar a taxa de crescimento viral, para aumentar o tamanho da placa de uma cultura viral, para reduzir o tempo de latência do crescimento de uma cultura viral, e para a cultura de vírus para a produção e fabricação |
| EP2746386A1 (en) * | 2012-12-21 | 2014-06-25 | Lonza Cologne GmbH | Materials and methods for cell culture |
| WO2016159179A1 (ja) * | 2015-03-30 | 2016-10-06 | 味の素株式会社 | ヒト血清アルブミンを含む神経幹細胞増殖培地 |
| WO2023147342A2 (en) * | 2022-01-25 | 2023-08-03 | Takeda Vaccines, Inc. | Large-scale flaviviral vaccine production and manufacture |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5024947A (en) | 1987-07-24 | 1991-06-18 | Cetus Corporation | Serum free media for the growth on insect cells and expression of products thereby |
| US5616487A (en) * | 1994-09-15 | 1997-04-01 | Aastrom Biosciences, Inc. | Stabilized retrovirus compositions |
| EP2243827B2 (en) * | 1996-08-30 | 2017-11-22 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
| WO1998013500A2 (en) * | 1996-09-24 | 1998-04-02 | Bavarian Nordic Research Institute A/S | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines |
| US7732129B1 (en) * | 1998-12-01 | 2010-06-08 | Crucell Holland B.V. | Method for the production and purification of adenoviral vectors |
| DE50005155D1 (de) | 1999-10-08 | 2004-03-04 | Gruenenthal Gmbh | Bicyclische imidazo-3-yl-aminderivate |
| AU3844101A (en) * | 2000-02-16 | 2001-08-27 | Us Health | Avirulent, immunogenic flavivirus chimeras |
| AU2003205169A1 (en) * | 2002-01-15 | 2003-07-30 | Acambis, Inc. | Viral vaccine production method |
| WO2003084479A2 (en) * | 2002-03-29 | 2003-10-16 | Merck & Co., Inc. | Large scale methods of producing adenovirus and adenovirus seed stocks |
| RU2237065C2 (ru) | 2002-10-03 | 2004-09-27 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Иммуногенная библиотека химерных пептидов, мимикрирующая генетическое многообразие гипервариабельного района v3 белка оболочки gp120 вируса иммунодефицита человека |
| PL199642B1 (pl) * | 2002-11-15 | 2008-10-31 | Inst Immunologii I Terapii Do | Preparat bakteriofagowy o podwyższonej trwałości oraz zastosowanie blokowego kopolimeru tlenku etylenu i tlenku propylenu |
| US20100068147A1 (en) * | 2006-10-05 | 2010-03-18 | Agency for Science , Technology and Research | Dengue diagnosis and treatment |
| KR20170038110A (ko) | 2007-04-06 | 2017-04-05 | 다케다 백신즈 인코포레이티드 | 살아있는 약독화된 바이러스를 위한 방법 및 조성물 |
| US8367370B2 (en) * | 2008-02-11 | 2013-02-05 | Wheeler Aaron R | Droplet-based cell culture and cell assays using digital microfluidics |
| BR122020015754B8 (pt) | 2008-12-05 | 2021-04-06 | Takeda Vaccines Inc | métodos para aumentar a taxa de crescimento viral, para aumentar o tamanho da placa de uma cultura viral, para reduzir o tempo de latência do crescimento de uma cultura viral, e para a cultura de vírus para a produção e fabricação |
-
2009
- 2009-12-04 BR BR122020015754A patent/BR122020015754B8/pt active IP Right Grant
- 2009-12-04 KR KR1020117015005A patent/KR101784951B1/ko active IP Right Grant
- 2009-12-04 TW TW103132644A patent/TWI573874B/zh active
- 2009-12-04 BR BRPI0922788A patent/BRPI0922788B8/pt active IP Right Grant
- 2009-12-04 WO PCT/US2009/066848 patent/WO2010065911A1/en active Application Filing
- 2009-12-04 NZ NZ593415A patent/NZ593415A/en unknown
- 2009-12-04 TW TW098141534A patent/TWI461536B/zh active
- 2009-12-04 SG SG10201503671TA patent/SG10201503671TA/en unknown
- 2009-12-04 MY MYPI2011002552A patent/MY178195A/en unknown
- 2009-12-04 EP EP09831233.3A patent/EP2366024B1/en active Active
- 2009-12-04 CN CN201510470646.0A patent/CN105219734B/zh active Active
- 2009-12-04 AU AU2009322175A patent/AU2009322175B2/en active Active
- 2009-12-04 SG SG10202007719TA patent/SG10202007719TA/en unknown
- 2009-12-04 CN CN200980154016.5A patent/CN102272294B/zh active Active
- 2009-12-04 US US12/631,629 patent/US8871487B2/en active Active
- 2009-12-04 JP JP2011539758A patent/JP5728742B2/ja active Active
- 2009-12-04 AR ARP090104712A patent/AR074483A1/es active IP Right Grant
- 2009-12-04 SG SG2011040961A patent/SG171972A1/en unknown
- 2009-12-04 CA CA2745962A patent/CA2745962C/en active Active
- 2009-12-04 MX MX2011005886A patent/MX2011005886A/es active IP Right Grant
-
2011
- 2011-06-03 MX MX2015008630A patent/MX353602B/es unknown
- 2011-06-05 IL IL213389A patent/IL213389B/en active IP Right Grant
- 2011-06-06 CU CU20110128A patent/CU20110128A7/es unknown
- 2011-06-10 ZA ZA2011/04364A patent/ZA201104364B/en unknown
- 2011-06-17 CO CO11076067A patent/CO6390063A2/es not_active Application Discontinuation
-
2014
- 2014-09-19 US US14/491,805 patent/US9890362B2/en active Active
-
2015
- 2015-03-12 JP JP2015049625A patent/JP6174066B2/ja active Active
- 2015-05-14 IL IL238819A patent/IL238819A/en active IP Right Grant
-
2016
- 2016-01-26 ZA ZA2016/00550A patent/ZA201600550B/en unknown
-
2017
- 2017-12-28 US US15/856,770 patent/US20180251737A1/en not_active Abandoned
-
2019
- 2019-07-23 HR HRP20191324TT patent/HRP20191324T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1250936A1 (zh) | 用於治療病毒感染的化合物和方法 | |
| ZA201006944B (en) | Compositions and methods for preparing and using same | |
| EP2244380A4 (en) | predistorter | |
| ZA201203603B (en) | Lyophilization methods, compositions, and kits | |
| GB0807424D0 (en) | Virus | |
| GB0822068D0 (en) | Methods for virus design | |
| HK1215025A1 (zh) | 純化的吡咯並喹啉基-吡咯烷- -二酮組合物和用於製備且使用其的方法 | |
| GB0706077D0 (en) | Methods, Compositions and uses thereof | |
| EP2285405A4 (en) | VACCINE COMPOSITIONS AND METHODS | |
| ZA201600550B (en) | Compositions, methods and uses for inducing viral growth | |
| IL214211A0 (en) | Stable vaccine compositions and methods for preparing the same | |
| HRP20150021T1 (en) | Phenanthrenone compounds, compositions and methods | |
| GB0801122D0 (en) | Vaccine composition | |
| GB0823560D0 (en) | Virus | |
| GB0815069D0 (en) | Viral inactivation | |
| GB0802326D0 (en) | Vaccine Composition | |
| GB0810378D0 (en) | Virus | |
| GB0813823D0 (en) | Virus | |
| GB0811276D0 (en) | Viral inactivation process | |
| GB0803779D0 (en) | Viral inactivation process | |
| GB0901234D0 (en) | Composition,method and use | |
| GB0901293D0 (en) | Composition, method and use | |
| GB0901227D0 (en) | Composition,method and use |